VSNL1 co-expression networks in aging include calcium signaling, synaptic plasticity, and Alzheimer's disease pathways

Frontiers in Psychiatry

Volumn 6, Issue MAR, 2015, Pages

  Lin, Chien Wei ^a   Chang, Lun Ching ^a   Tseng, George C ^a   Kirkwood, Caitlin M ^b   Sibille, Etienne L ^b,c   Sweet, Robert A ^b,d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Calcium signaling; Co expression networks; Synaptic plasticity; Visinin like 1; Visinin like protein 1

Indexed keywords

AMPA RECEPTOR; AMYLOID PRECURSOR PROTEIN; PROTEIN P35;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; FRONTAL CORTEX; GENE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LIFESPAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MAJOR CLINICAL STUDY; NERVE CELL PLASTICITY; NEUROPATHOLOGY; P35 GENE; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; VSNL1 GENE;

EID: 84926656550     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00030     Document Type: Article

References (50)

1. Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 2:a006239. doi:10.1101/cshperspect.a006239
2. Selkoe DJ. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med (2004) 140:627-38. doi:10.7326/0003-4819-140-8-200404200-00010
3. Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci (2007) 8:663-72. doi:10.1038/nrn2194
4. Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology (2004) 62:925-31. doi:10.1212/01.WNL.0000115115.98960.37
5. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 30:572-80. doi:10.1002/ana.410300410
6. Scheff SW, Price DA. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging (2003) 24:1029-46. doi:10.1016/j.neurobiolaging.2003.08.002
7. Baloyannis SJ, Costa V, Mauroudis I, Psaroulis D, Manolides SL, Manolides LS. Dendritic and spinal pathology in the acoustic cortex in Alzheimer's disease: morphological and morphometric estimation by Golgi technique and electron microscopy. Acta Otolaryngol (2007) 127:351-4. doi:10.1080/00016480601126986
8. Grutzendler J, Helmin K, Tsai J, Gan WB. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann N Y Acad Sci (2007) 1097:30-9. doi:10.1196/annals.1379.003
9. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science (2002) 298:789-91. doi:10.1126/science.1074069
10. Selkoe DJ. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res (2008) 192:106-13. doi:10.1016/j.bbr.2008.02.016
11. Walsh DM, Selkoe DJ. A beta oligomers - a decade of discovery. J Neurochem (2007) 101:1172-84. doi:10.1111/j.1471-4159.2006.04426.x
12. Koffie RM, Hyman BT, Spires-Jones TL. Alzheimer's disease: synapses gone cold. Mol Neurodegener (2011) 6:63. doi:10.1186/1750-1326-6-63
13. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 155:853-62. doi:10.1016/S0002-9440(10)65184-X
14. Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. J Am Med Assoc (2000) 283:1571-7. doi:10.1001/jama.283.12.1571
15. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron (2006) 52:831-43. doi:10.1016/j.neuron.2006.10.035
16. Lee JM, Blennow K, Andreasen N, Laterza O, Modur V, Olander J, et al. The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients. Clin Chem (2008) 54:1617-23. doi:10.1373/clinchem.2008.104497
17. Tarawneh R, D'Angelo G, Macy E, Xiong C, Carter D, Cairns NJ, et al. Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease. Ann Neurol (2011) 70:274-85. doi:10.1002/ana.22448
18. Tarawneh R, Lee JM, Ladenson JH, Morris JC, Holtzman DM. CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology (2012) 78:709-19. doi:10.1212/WNL.0b013e318248e568
19. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 9:119-28. doi:10.1016/S1474-4422(09)70299-6
20. Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, et al. Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2012) 17:1316-27. doi:10.1038/mp.2011.125
21. Ropacki SA, Jeste DV. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry (2005) 162:2022-30. doi:10.1176/appi.ajp.162.11.2022
22. Murray PS, Kumar S, DeMichele-Sweet MA, Sweet RA. Psychosis in Alzheimer's disease. Biol Psychiatry (2014) 75:542-52. doi:10.1016/j.biopsych.2013.08.020
23. Braunewell K, Riederer P, Spilker C, Gundelfinger ED, Bogerts B, Bernstein HG. Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cogn Disord (2001) 12:110-6. doi:10.1159/000051244
24. Schnurra I, Bernstein HG, Riederer P, Braunewell KH. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease? Neurobiol Dis (2001) 8:900-9. doi:10.1006/nbdi.2001.0432
25. Burgoyne RD, Weiss JL. The neuronal calcium sensor family of Ca2+-binding proteins. Biochem J (2001) 353:1-12. doi:10.1042/0264-6021:3530001
26. Braunewell KH, Klein-Szanto AJ. Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+ -sensor proteins. Cell Tissue Res (2009) 335:301-16. doi:10.1007/s00441-008-0716-3
27. Palmer CL, Lim W, Hastie PG, Toward M, Korolchuk VI, Burbidge SA, et al. Hippocalcin functions as a calcium sensor in hippocampal LTD. Neuron (2005) 47:487-94. doi:10.1016/j.neuron.2005.06.014
28. Amici M, Doherty A, Jo J, Jane D, Cho K, Collingridge G, et al. Neuronal calcium sensors and synaptic plasticity. Biochem Soc Trans (2009) 37:1359-63. doi:10.1042/BST0371359
29. Erraji-Benchekroun L, Underwood MD, Arango V, Galfalvy H, Pavlidis P, Smyrniotopoulos P, et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry (2005) 57:549-58. doi:10.1016/j.biopsych.2004.10.034
30. Shabalin AA. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics (2012) 28:1353-8. doi:10.1093/bioinformatics/bts163
31. Li J, Tseng GC. An adaptively weighted statistic for detecting differential gene expression when combining multiple transcriptomic studies. Ann Appl Stat (2011) 5:994-1019. doi:10.1214/10-AOAS393
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol (1995) 57:289-300.
33. Glorioso C, Oh S, Douillard GG, Sibille E. Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism. Neurobiol Dis (2011) 41:279-90. doi:10.1016/j.nbd.2010.09.016
34. Saab BJ, Georgiou J, Nath A, Lee FJ, Wang M, Michalon A, et al. NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory. Neuron (2009) 63:643-56. doi:10.1016/j.neuron.2009.08.014
35. Lin L, Jeanclos EM, Treuil M, Braunewell KH, Gundelfinger ED, Anand R. The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the alpha 4beta 2 nicotinic acetylcholine receptor. J Biol Chem (2002) 277:41872-8. doi:10.1074/jbc.M206857200
36. Glorioso C, Sibille E. Between destiny and disease: genetics and molecular pathways of human central nervous system aging. Prog Neurobiol (2011) 93:165-81. doi:10.1016/j.pneurobio.2010.11.006
37. Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, et al. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet (2012) 8:e1002707. doi:10.1371/journal.pgen.1002707
38. Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains. PLoS One (2012) 7:e50976. doi:10.1371/journal.pone.0050976
39. Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 79:221-8. doi:10.1212/WNL.0b013e3182605801
40. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ, et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet (2008) 17:1156-68. doi:10.1093/hmg/ddn005
41. Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Marangoni S, Novello JC, et al. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm (2009) 116:275-89. doi:10.1007/s00702-008-0156-y
42. Braunewell KH, Dwary AD, Richter F, Trappe K, Zhao C, Giegling I, et al. Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology. Transl Psychiatry (2011) 1:e22. doi:10.1038/tp.2011.20
43. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, et al. Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 11:1271-82. doi:10.1038/nn.2207
44. Gaiteri C, Ding Y, French B, Tseng GC, Sibille E. Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav (2014) 13:13-24. doi:10.1111/gbb.12106
45. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature (2012) 489:391-9. doi:10.1038/nature11405
46. Allocco DJ, Kohane IS, Butte AJ. Quantifying the relationship between co-expression, co-regulation and gene function. BMC Bioinformatics (2004) 5:18. doi:10.1186/1471-2105-5-18
47. Ebisuya M, Yamamoto T, Nakajima M, Nishida E. Ripples from neighbouring transcription. Nat Cell Biol (2008) 10:1106-13. doi:10.1038/ncb1771
48. Homouz D, Kudlicki AS. The 3D organization of the yeast genome correlates with co-expression and reflects functional relations between genes. PLoS One (2013) 8:e54699. doi:10.1371/journal.pone.0054699
49. Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, et al. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol (2012) 13:R97. doi:10.1186/gb-2012-13-10-r97
50. Gennarino VA, D'Angelo G, Dharmalingam G, Fernandez S, Russolillo G, Sanges R, et al. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res (2012) 22:1163-72. doi:10.1101/gr.130435.111